Execution intact, transition headwinds persist; multi-year view intact

Interest income ₹363 Cr up 19% YoY; portfolio yield 18.1% up 63 bps QoQ from high-yield EM/GROx mix shift

Q1 opex ₹119 Cr (₹476 Cr annualized); down 42% QoQ from Q4 ₹217 Cr, down 2% YoY. Matches stated ~₹220 Cr reduction plan

AUM ₹3,581 Cr (Mar) to ₹3,896 Cr (Jun), 9% QoQ growth. Branches >12 months: ₹81 Lakh/month (target ₹80-85 Lakh). Within expectations

GROx AUM ₹2,280 Cr to ₹3,003 Cr (32% QoQ). Disbursements ₹1,853 Cr, 60k+ loans/month, 3.4 Lakh active customers, 26% yield, 2.1% GNPA

Co-lend/DA ₹75 Cr (14% of ₹535 Cr total income) vs ₹155 Cr in Q4 (24% of Q4 income). Exactly as guided

EM LAP GNPA 2.1%, Embedded Finance 2.1%, overall AUM GNPA 2.6%. Management reiterated peaks projected at 3%-3.5% for EM, <3% for Embedded based on seasoning

Q1 opex ₹119 Cr (₹476 Cr annualized run rate) vs ₹217 Cr Q4. Stated 'approximately ₹220 Cr annualized reduction' delivered; all action complete. Opex expected flat rest of FY27.

₹155 Cr (Q4) → ₹75 Cr (Q1), 52% decline. Management confirmed this is the run rate for FY27; end of 12-quarter journey to 4% by Q4 FY28 matches prior guidance.

EM LAP growing faster than 25% (9% QoQ = ~40% annualized), GROx 32% QoQ (>25%). On pace to exceed 85% of AUM by FY29 target. Execution momentum strengthening.

Portfolio exiting faster than planned; foreclosures of DSA book higher. Creates income reversal headwind short-term but accelerates transition. Management candid: 'simultaneously accelerating intended transition.'

Combined EM + GROx capacity at ₹1,000 Cr/month (July standalone, not embedded in Q1 numbers). Validates dual-engine scaling thesis; new capacity floor.

FY27 AUM flat; on-balance sheet assets growing. FY29 guidance: EM 25% CAGR, GROx 25% CAGR, Prime -20% rundown (actual -25%). Overall ~15% AUM growth FY27–FY29. ROE now 9.2%; path to higher levels via ROA expansion.

Q1 is the base. Opex now flat. Interest income will grow QoQ from here as on-balance sheet assets grow. Co-lend at ₹75 Cr is run rate for FY27 (function of foreclosure pace). ROA normalized at 2.1%, pathway to 3–3.5% via leverage.

Projection well within expectations. EM LAP peak delinquencies 3.5%–4% when avg tenure 18 months (currently 15 months). Embedded Finance expected <3% (vs higher prior projection). Credit cost EM LAP 1.5%–2% guidance held.

Sale requires 6-month vintage (not all DSA has it). Piecemeal sale uneconomical (collection infrastructure fixed). On-balance sheet and off-balance sheet mix; full sale triggers large income reversal. Expects market to understand runoff narrative in 1–2 more quarters.

Profectus at 1.1x book, generates more cash than goodwill paid. Acquisition was sound. Current valuation driven by PE fund exits (50% held by 4–5 PE investors), Iran war timing, and mutual fund market-cap bias for IPO entry. Expects reset when growth trajectory becomes established.

Credit risk (both engines small-ticket customers, early warning signals post-Middle East war, daily monitoring via GROx). Cost of borrowing (improving but not yet factored into FY29 projections). Not explicitly detailed third.

Three execution risks: (1) EM branch <6-month cohort (145 branches) must scale to ₹75–80 Lakh/month by 12-month mark. (2) GROx expansion into longer-tenure, higher-ticket assets (marketplaces) risks credit deterioration. (3) Runoff presumed 20% but actual 25%; if too fast, income reversal pressure. All being monitored; July showed branch targets achievable.

Contingent on opex staying flat (delivered in Q1) and co-lend/DA stabilizing at ₹75 Cr run rate. Depends on AUM inflection beginning in H2 FY27.

EM LAP growing faster than 25% (9% QoQ), GROx 32% QoQ. Track record of exceeding guidance. Assumes credit discipline holds as GROx expands into longer-tenure assets.

Running faster than guided (25% vs 20%), accelerating transition. Intensity may moderate as portfolio base shrinks in H2.

Assumes 3 drivers hold: (1) opex stays flat (not declining further), (2) interest income grows with AUM, (3) co-lend/DA remains at 14% of total income declining to 4%. Post-tax ROE today 9.2%; path to 15%+ requires ROA inflection.

EM LAP at 18.5%, GROx at 26%. Blended yield of 46% of AUM mix is strong. Assumes Prime rundown (lower yield) continues at >20% annually.

Assumes no major stress on capital adequacy (now 21% standalone, ~23–24% on merged basis post-NCLT). Contingent on GNPA staying below 3.5% peak, profitability sustaining, and AUM growth within leverage tolerance.

EM LAP GNPA at 2.1% (peak expected 3.5%–4% at 18-month seasoning; currently 15 months). GROx GNPA 2.1% (peak expected <3%). If both breach peaks, credit cost could exceed 1.5–2% guidance, compressing margins by 50–100 bps.

Prime rundown at 25% annualized vs 20% guided. Runoff embeds income reversals (off-balance sheet co-lend/DA contracts running off faster than amortization schedule). If acceleration continues >30%, reversal impacts could pressure reported profitability despite operational improvements.

Interest income ₹363 Cr down 13% QoQ despite 20% YoY growth. On-book interest earned only on on-balance sheet portfolio; off-balance sheet DSA foreclosure upfront DSA cost recognition creates income reversal bucket. If on-balance sheet asset growth doesn't accelerate, interest income could remain suppressed through FY27.

145 branches less than 6 months old must scale to ₹75–80 Lakh/month by 12-month mark to offset Prime rundown. If branch productivity lags (stays at ₹30–40 Lakh range longer), EM LAP AUM growth may not offset rundown, extending AUM flatness beyond FY27.

Cost of borrowing improved 41 bps YoY to 10.14% (7th consecutive quarterly improvement). Management hopes continued decline as AUM scales, but has NOT baked into FY29 projections. If AUM growth stalls, funding cost may plateau or rise, capping ROA upside.